Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03784508
Other study ID # PR(AG)320-2018
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 1, 2018
Est. completion date April 1, 2022

Study information

Verified date February 2021
Source Hospital Universitari Vall d'Hebron Research Institute
Contact Andreea Ciudin, MD, PhD
Phone 697817352
Email aciudin@vhebron.net
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The prevalence of obesity in Spain is about 21.6%. The discouraging results provided by dietary treatment, together with the lack of funding for pharmacological treatment, have led to the progressive use of bariatric surgery (CB). Besides weight loss, CB associates a beneficial effect on metabolic comorbidities. However, 25-30% of operated patients present a weight response considered inappropriate, they do not resolve their comorbidities and/or present a weight-regain shortly after surgery. Therefore, predictive strategies are necessary to allow a correct selection of obese patients who are candidates for CB. The main hypothesis of the study is that various factors such as psychopathological profile, body composition and metabolic alterations related to morbid obesity can influence the response to bariatric surgery.


Description:

The investigators have designed a prospective study in which 200 consecutive patients from the outpatient clinic of the Morbidly Obesity Unit of the Vall d'Hebron Hospital will be included, meeting criteria for bariatric surgery (with BMI> 40 kg / m2 or BMI> 35 kg /m2 in the presence of comorbidities) and will undergo surgery in the investigator's center between September 2018 and September 2019. All patients will undergo (baseline, month, 6, 12 and 24 month): complete clinical history, analysis complete biochemistry, 2 blood samples will be extracted to study metabolomics, stool sample for microbiota study, bioimpedance for the study of body composition, determination of AGEs in the skin and lens, cognitive function assessment, retinal function assessment by microperimetry and they will be asked to complete several specific questionnaires for the evaluation of the psychopathological profile and the dietetic survey.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date April 1, 2022
Est. primary completion date December 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patients fulfilling criteria for bariatric surgery (BS). - Signed informed consent fir the BS and the study. - Previous accomplishment of the preoperative protocol for the BS at our site. - undergo BS between September 2018 and December 2019 - Able to read and understand the specific questionnaires. Exclusion Criteria: - Any contraindication for the bariatric surgery. - Impossibility to follow-up at our site (eg: patients from outside out community).

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Spain Andreea Ciudin Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Hospital Universitari Vall d'Hebron Research Institute

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evolution of the body mass index in morbidly obesity patients after bariatric surgery (BS). For the assessment of the evolution after bariatric surgery the investigators will use the body mass index parameter (BMI), calculated with the following formula: Body mass index (BMI) will be calculated as weight (kg)/height (m2).
Changes in BMI, will be evaluated at 1, 6, 12 and 24 month after bariatric surgery.
24month
Primary Evolution of the excess of weight loss % (EWL%) after bariatric surgery. - Excess of weight loss % (EWL%) will be calculated using the following formula: pre-bariatric surgery weight (kg)-visit weight (kg)/pre-bariatric surgery weight (kg)- ideal weight (for BMI 25) (kg) x 100%. Changes in EWL% will be evaluated at 1, 6, 12 and 24 month after bariatric surgery. 24 month
Primary Evolution of the total weight loss after bariatric surgery -Total weight loss (TWL) will be calculated as: pre-bariatric surgery weight (kg)- visit weight (kg). Changes in TWL will be evaluated at 1, 6, 12 and 24 month after bariatric surgery. 24 month
Secondary Evaluation of the body composition scores before and after bariatric surgery by means of bioimpedanciometry. All the patients will undergo before and after bariatric surgery (after 1,6, 12, and 24 month) the bioimpedance Bodystat QuadScan 4000 evaluation. The results are expressed in kg of free fatty mass and fatty mass. The change in Kg of the free fatty mass and fatty mass regarding the baseline will be evaluated. 24 month
Secondary Evaluation of the Advanced Glycation End products (AGEs) before and after bariatric surgery. All the patients will undergo AGEs evaluation before, at 6, 12, 24 months after bariatric surgery (eye and skin using CLEARPATH DS-120 and microCAYA-AGEreader respectively). The presence of the AGEs is automatically calculated as standard deviation from the normal values for age and gender. The differences between the baseline value, at 6,12 and 24 month will be evaluated. 24 month
Secondary Evaluation of neuropsychological scores before and after bariatric surgery: eating attitudes Eating Attitudes Test (EAT) evaluates the possible eating disorders of the patients. The test will be used before, at 6, 12, and 24month after bariatric surgery and the scores will be compared. The investigators will search for correlations with the BMI, EWL% and TWL changes. The subjects will have to answer 40 items, each of it measured from 0 to 3, total score may range between 0 and 120. The accepted cut-off for diagnosis eating disorders is more than 20 for spanish population. 24month
Secondary Evaluation of neuropsychological scores before and after bariatric surgery: Attention-Deficit Hyperactivity Disorder (ADHD) ADHD rating scale will be used before, at 6, 12, and 24month after bariatric surgery and the scores will be compared. The investigators will evaluate the existence of correlations with the BMI, EWL% and TWL changes. The scale ranges between 0-27 points, the highest the value, the higher de attention deficit and hyperactivity. 24month
Secondary Evaluation of neuropsychological scores before and after bariatric surgery: Sheehan Disability Inventory (SDI). Sheehan Disability Inventory (SDI) scale will be used before, at 6, 12, and 24month after bariatric surgery and the scores will be compared. The investigators will evaluate the existence of correlations with the BMI, EWL% and TWL changes. The Sheehan Disability Inventory evaluates the social fobia and the score ranges between 0-30. A score > 15 is considered pathological. 24 month
Secondary Evaluation of neuropsychological scores before and after bariatric surgery: Zuckerman-Kuhlman Personality Questionnaire (ZKPQ). ZKPQ personality evaluation will be used before, at 6, 12, and 24month after bariatric surgery and the scores will be compared. The investigators will evaluate the existence of correlations with the BMI, EWL% and TWL changes. ZKPQ is a quantitative scale which evaluates 6 personality dimensions: aggressivity (19 points), anxiety (19 points), impulsivity (17 points), activity (17 points), sociability (17 points). There is no clear cut-off for this test. In consequence, there will be evaluated only the changes after the bariatric surgery, compared with the baseline score. The higher the score the higher the personality disorder. 24month
Secondary Evaluation of neuropsychological scores before and after bariatric surgery: COPE- stress management strategies. COPE test will be used before, at 6, 12, and 24month after bariatric surgery and the scores will be compared. The investigators will evaluate the existence of correlations with the BMI, EWL% and TWL changes. COPE is a quantitative scale which evaluates 15 strategies of stress coping. The total score ranges between 15-60 points. There is a direct relation between the score and the ability to manage the stress, but no clear cut-off for this test exists. In consequence, we will only evaluate the changes after the bariatric surgery regarding the baseline score. The highest score indicates better strategies to cope the stress. 24month
Secondary Evaluation of neuropsychological scores before and after bariatric surgery: ROTTER´s locus of control scale. ROTTERĀ“s locus of control scale test will be used before, at 6, 12, and 24month after bariatric surgery and the scores will be compared. The investigators will evaluate the existence of correlations with the BMI, EWL% and TWL changes. COPE is a quantitative scale which a total score ranging between 0-29 points. The cut-off value <15 defines the internal locus of control. 24month
Secondary Evaluation of neuropsychological scores before and after bariatric surgery: YALE food addiction. YALE food addiction scale test will be used before, at 6, 12, and 24month after bariatric surgery and the scores will be compared. The investigators will evaluate the existence of correlations with the BMI, EWL% and TWL changes. There is a direct relation between the score and the food addiction, is a quantitative scale but there is no clear cut-off. There will be evaluated the changes in the score at 6,12, and 24 month after the bariatric surgery, comparing with baseline. The highest the score, the higher the food addiction. 24month
Secondary Evaluation of neuropsychological scores before and after bariatric surgery:The Bariatric Analysis and Reporting Outcome System (B.A.R.OS). B.A.R.O.S test will be used before, at 6, 12, and 24month after bariatric surgery and the scores will be compared. The investigators will evaluate the existence of correlations with the BMI, EWL% and TWL changes. B.A.R.O.S. is a quantitative questionnaire evaluating the quality of life after the bariatric surgery. The scale ranges between 0 and 9. The higher the score the highest the quality of life of the patient. 24month
Secondary Evaluation of neuropsychological scores before and after bariatric surgery: The State-Trait Anxiety Inventory (STAI). STAI anxiety questionnaire evaluates the degree of the anxiety of the patient and will be used before, at 6, 12, and 24month after bariatric surgery and the scores will be compared. The investigators will evaluate the existence of correlations with the BMI, EWL% and TWL changes. The score ranges between 0 and 60. A cut-off value> 19 is considered pathological anxiety. 24month
Secondary Evaluation of neuropsychological scores before and after bariatric surgery: WPAI (working productivity questionnaire). WPAI questionnaire will be used before, at 6, 12, and 24month after bariatric surgery and the results will be compared. The investigators will evaluate the existence of correlations with the BMI, EWL% and TWL changes. There is a qualitative score, evaluating the working status of the patient: retiree, active, off-work>6month, unemployed, permanent occupational disability. Percentages of each category will be evaluated at each time. Ej: % of unemployed, etc. 24month
Secondary Evaluation of neuropsychological scores before and after bariatric surgery: Beck Depression Inventory (BDI) BDI evaluates if depression exists and its degree. It will be used before, at 6, 12, and 24month after bariatric surgery and the results will be compared. The investigators will evaluate the existence of correlations with the BMI, EWL% and TWL changes. The score ranges between 0-40. 0-10: normal; 10-16 mild emotional; 17-20: borderline clinical depression; 21-30 moderate depression; 31-40 severe depression. 24month
Secondary Evaluation of the congnitive function before and after bariatric surgery Minimental State Evaluation Test and Montreal Cognitive Assessment test will be used before and at 12 and 24 month after bariatric surgery 24 month
Secondary Evaluation of the utility of the retinal function evaluation in the detection of cognitive disfunction before and after bariatric surgery Retinal microperimetry using MAIA 3rd generation microperimeter will be used before and at 12 and 24 month after the bariatric surgery 24 month
See also
  Status Clinical Trial Phase
Completed NCT03657927 - A Comparison of McGrath MAC Versus C-MAC Videolaryngoscopes in Morbidly Obese Patients N/A
Recruiting NCT04934826 - Comparison of the Absorption of Hydrolyzed or Intact Proteins in Morbid Obese Patients After the Roux Y Gastric Bypass N/A
Completed NCT03181347 - The Microbiology of Bariatric Surgery N/A
Completed NCT03886870 - Obesity, Lifestyle and Work Intervention N/A
Active, not recruiting NCT04433338 - The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery N/A
Completed NCT03553849 - Utilization of Very Low Calorie Diet in Obese General Surgery Patients N/A
Completed NCT05854875 - Diabetes Remission After RYGBP and RYGBP With Fundus Resection N/A
Not yet recruiting NCT03203161 - Registry on Obesity Surgery in Adolescents
Not yet recruiting NCT03601273 - Bariatric Embolization Trial for the Obese Nonsurgical Phase 1
Recruiting NCT02129296 - Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study Phase 1/Phase 2
Active, not recruiting NCT01564732 - Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding N/A
Completed NCT02033265 - Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity
Completed NCT01963637 - Gastric Volumetry by Gastric Tomodensitometry With Gas N/A
Not yet recruiting NCT01652105 - Randomized Trial of Preoperative Diets Before Bariatric Surgery N/A
Completed NCT01955993 - Fentanyl Metabolism in Obese Adolescents N/A
Terminated NCT01759550 - Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
Completed NCT01149512 - Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program N/A
Recruiting NCT01685177 - Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient N/A
Completed NCT01675713 - Lifestyleintervention for the Treatment of Severe Obesity N/A
Terminated NCT01041261 - Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery N/A